Oman’s ruler, Sultan Haitham bin Tariq, has given the go ahead for RO300 million ($779m) to be spent on developmental projects to support the country’s economic growth, according to the state-run Oman ... ( read original story ...)
Oman to close Dhofar Governorate from 12 noon of June 13 until July 3 for tourism
Life is far more precious than business and tourism,” is general reaction from people when asked about the Supreme Committee’s decision to close Dhofar Governorate from 12 noon of June 13 until July 3 ... ( read original story ...)
Coronavirus: Oman reports 689 new Covid-19 cases
The Ministry of Health in Oman on Wednesday reported 689 new cases of the Covid-19 coronavirus, along with 177 recoveries. Of the new cases, 334 were Omanis while 355 were non-Omanis. With this, a ... ( read original story ...)
Emerging from the bubble: Oman’s tourism and hospitality prospects
Hotel industry here in Oman should be able to adapt relatively quickly, although older, one- and two-star establishments will find it difficult to retain any semblance of a clientele ... ( read original story ...)
Tiny Singapore Replaces U.S. as India’s Top Market for Engineering Exports
India's overall engineering exports, comprising industrial machinery and auto parts, constitute nearly a quarter of total goods exports, contracting in April and May due to the coronavirus and weak ... ( read original story ...)
Singapore approves Gilead’s remdesivir for COVID-19 treatment
Singapore's Health Sciences Authority said on Wednesday it granted conditional approval for Gilead Sciences Inc's antiviral drug remdesivir for the treatment of some patients with COVID-19 infection. ( read original story ...)
Singapore approves anti-viral drug for COVID-19 patients
Singapore has approved the use of the anti-viral drug remdesivir to treat seriously ill coronavirus patients, authorities said Wednesday, becoming the latest country to do so. It has been granted ... ( read original story ...)
Singapore approves remdesivir drug for emergency COVID-19 treatment
Singapore on Wednesday approved the use of Gilead Sciences Inc's antiviral drug remdesivir for the treatment of severely ill patients with COVID-19 infection. Remdesivir is the first drug shown to be ... ( read original story ...)
Ince Brings Singapore Alliance Firm Into Fold After Several Exits
The two firms had been in an alliance for almost a decade, but had recently seen a number of senior departures. ( read original story ...)
Singapore biotech firm Tychan to start human trials for COVID-19 treatment next week
A Singaporean biotechnology firm, Tychan, will begin human clinical trials next week for a potential monoclonal antibody treatment for COVID-19, it said in a statement on Wednesday. ( read original story ...)